99% Savings - Buy Just @1 Rs X
Glitaris M 7.5 Tablet SR is a commercial drug that is prescribed in the form of Tablet. Other than this, Glitaris M 7.5 Tablet SR has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Glitaris M 7.5 Tablet SR is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The most common side effects of Glitaris M 7.5 Tablet SR are Stomach Upset, Difficulty urinating, Muscle Ache. Besides the aforementioned side effects, there are other adverse effects of Glitaris M 7.5 Tablet SR as well, which are listed below. These side effects of Glitaris M 7.5 Tablet SR are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Glitaris M 7.5 Tablet SR is Moderate for pregnant women and Moderate for women who are breastfeeding. Further, the section on Glitaris M 7.5 Tablet SR related warnings talks about Glitaris M 7.5 Tablet SR's effects on the liver, heart and kidney.
Glitaris M 7.5 Tablet SR can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Glitaris M 7.5 Tablet SR in conditions like Congestive Heart Failure (CHF), Anemia, Shock. Some other conditions that can be affected by Glitaris M 7.5 Tablet SR are listed in the contraindications section below.
Additionally, Glitaris M 7.5 Tablet SR may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Glitaris M 7.5 Tablet SR is considered safe while driving, and is addictive.
Glitaris M 7.5 Tablet SR is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glitaris M 7.5 Tablet SR safe for pregnant women?
Glitaris M can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Glitaris M right away. Take your doctor's advice before taking it again.
Is the use of Glitaris M 7.5 Tablet SR safe during breastfeeding?
Breastfeeding women may feel side effects of Glitaris M. If you see any side effects, stop taking Glitaris M immediately and talk to your doctor. Take Glitaris M again, only after your doctor's advice.
What is the effect of Glitaris M 7.5 Tablet SR on the Kidneys?
Very few cases of side effects of Glitaris M on kidney have been reported.
What is the effect of Glitaris M 7.5 Tablet SR on the Liver?
Glitaris M can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Glitaris M 7.5 Tablet SR on the Heart?
The heart can be affected by Glitaris M. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Glitaris M 7.5 Tablet SR unless your doctor advises you to do so -
Is this Glitaris M 7.5 Tablet SR habit forming or addictive?
Glitaris M 7.5 Tablet SR is not addictive in nature.
Interaction between Food and Glitaris M 7.5 Tablet SR
There isn't any research available on the side effects of taking Glitaris M 7.5 Tablet SR with food.
Interaction between Alcohol and Glitaris M 7.5 Tablet SR
Taking Glitaris M 7.5 Tablet SR and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
Yes, Glitaris M can cause some sleep problems, especially insomnia. On the other hand, Glitaris M has proven to be useful for preventing sleep apnea. The exact relationship between Glitaris M and sleep problems is still not clear, and further studies are needed for a clearer understanding.
Glitaris M helps in weight loss by reducing appetite and food intake. It also increases the insulin sensitivity in your body to work more effectively. This lead to decreased glucose production increases the use of glucose and decrease the fat deposition further helps in weight loss. However, Glitaris M is not approved for weight loss, this is an off-label use.
Yes, Glitaris M can be taken with the statin. There is no serious or harmful interaction have been observed between them. Some studies say that it's possible your blood sugar (blood glucose) level may increase when you take a statin, which may lead to developing type 2 diabetes. The risk is small but important enough that the Food and Drug Administration (FDA) has issued a warning on statin labels regarding blood glucose levels and diabetes.
Yes, Glitaris M can cause night sweat, the exact mechanism of sweating is not known. But some research suggests that Glitaris M causes hypoglycemia (low blood sugar) especially at night which can cause night sweats. Need to monitor your blood glucose level regularly, and talk to your doctor as your dose of Glitaris M may need to be adjusted.
Yes, Glitaris M is safe to use, many people have side effects at first, they usually diminish and then go away completely in a few weeks. A few people find they cannot tolerate metformin, there are other drugs but metformin is usually the first choice. It is very safe
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033